OneSpaWorld Holdings is rated Buy, leveraging a 90%+ cruise ship spa market share and strong operating leverage. Read more on ...
PTC Therapeutics delivered strong Q4 and FY2025 results, with full-year net product and royalty revenue of $831M, exceeding guidance. Sephience launched successfully, driving $111M in revenue since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results